Sensient Technologies Corporation

NYSE:SXT Stock Report

Market Cap: US$3.3b

Sensient Technologies Valuation

Is SXT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SXT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SXT ($78.25) is trading above our estimate of fair value ($75.81)

Significantly Below Fair Value: SXT is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for SXT?

Other financial metrics that can be useful for relative valuation.

SXT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.6x
Enterprise Value/EBITDA16.5x
PEG Ratio1.9x

Price to Earnings Ratio vs Peers

How does SXT's PE Ratio compare to its peers?

The above table shows the PE ratio for SXT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average22.5x
KWR Quaker Chemical
23.7x20.7%US$2.9b
ASH Ashland
24.2x13.5%US$4.2b
FUL H.B. Fuller
23.4x14.1%US$4.3b
IOSP Innospec
18.6x6.3%US$2.8b
SXT Sensient Technologies
37.9x19.8%US$3.3b

Price-To-Earnings vs Peers: SXT is expensive based on its Price-To-Earnings Ratio (37.9x) compared to the peer average (22.5x).


Price to Earnings Ratio vs Industry

How does SXT's PE Ratio compare vs other companies in the US Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a17.8%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a17.8%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: SXT is expensive based on its Price-To-Earnings Ratio (37.9x) compared to the US Chemicals industry average (25.4x).


Price to Earnings Ratio vs Fair Ratio

What is SXT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SXT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio37.9x
Fair PE Ratio20.7x

Price-To-Earnings vs Fair Ratio: SXT is expensive based on its Price-To-Earnings Ratio (37.9x) compared to the estimated Fair Price-To-Earnings Ratio (20.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SXT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$78.25
US$86.50
+10.5%
1.7%US$88.00US$85.00n/a2
Jul ’25US$73.66
US$79.00
+7.2%
1.3%US$80.00US$78.00n/a2
Jun ’25US$77.67
US$79.00
+1.7%
1.3%US$80.00US$78.00n/a2
May ’25US$73.65
US$79.00
+7.3%
1.3%US$80.00US$78.00n/a2
Apr ’25US$68.69
US$69.50
+1.2%
0.7%US$70.00US$69.00n/a2
Mar ’25US$66.68
US$69.50
+4.2%
0.7%US$70.00US$69.00n/a2
Feb ’25US$62.85
US$72.00
+14.6%
2.8%US$74.00US$70.00n/a2
Jan ’25US$66.00
US$72.00
+9.1%
2.8%US$74.00US$70.00n/a2
Dec ’24US$59.72
US$72.00
+20.6%
2.8%US$74.00US$70.00n/a2
Nov ’24US$56.03
US$75.50
+34.7%
7.3%US$81.00US$70.00n/a2
Oct ’24US$58.48
US$77.00
+31.7%
9.1%US$84.00US$70.00US$78.472
Sep ’24US$62.01
US$77.00
+24.2%
9.1%US$84.00US$70.00US$77.842
Aug ’24US$63.69
US$77.00
+20.9%
9.1%US$84.00US$70.00US$76.012
Jul ’24US$71.13
US$85.00
+19.5%
10.0%US$92.00US$73.00US$73.663
Jun ’24US$73.01
US$85.00
+16.4%
10.0%US$92.00US$73.00US$77.673
May ’24US$75.79
US$85.00
+12.2%
10.0%US$92.00US$73.00US$73.653
Apr ’24US$76.56
US$84.00
+9.7%
11.8%US$92.00US$70.00US$68.693
Mar ’24US$74.99
US$84.00
+12.0%
11.8%US$92.00US$70.00US$66.683
Feb ’24US$76.99
US$84.00
+9.1%
11.8%US$92.00US$70.00US$62.853
Jan ’24US$72.92
US$85.33
+17.0%
12.7%US$94.00US$70.00US$66.003
Dec ’23US$74.49
US$85.33
+14.6%
12.7%US$94.00US$70.00US$59.723
Nov ’23US$70.43
US$85.33
+21.2%
12.7%US$94.00US$70.00US$56.033
Oct ’23US$69.34
US$99.00
+42.8%
11.5%US$115.00US$90.00US$58.483

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies